Limited Ozempic supplies to commence distribution in Australia
- Joint statement: Supply allocations of intravenous tocilizumab (Actemra) during serious shortageTGA has published a Joint statement on supply allocations of intravenous tocilizumab (Actemra) during serious shortage.
- Consumers warned about Ozempic scamsThe TGA is aware of several scams targeting consumers seeking semaglutide (Ozempic). Consumers are strongly advised not to use products unless they have come from a trusted source.
- TGA cautions against over-buying medicinesStockpiling medicines may disrupt access to vital medicines by patients and pharmacies